These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23758840)

  • 1. Asymmetric kinase dimer formation is crucial for the activation of oncogenic EGFRvIII but not for ERBB3 phosphorylation.
    Kancha RK; von Bubnoff N; Duyster J
    Cell Commun Signal; 2013 Jun; 11():39. PubMed ID: 23758840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of EGFRwt/EGFRvIII homo- and hetero-dimers in glioblastoma cells as detected by single molecule localization microscopy.
    Jahnke K; Struve N; Hofmann D; Gote MJ; Bach M; Kriegs M; Hausmann M
    Nanoscale; 2024 Aug; 16(32):15240-15255. PubMed ID: 39073345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2Y2 nucleotide receptors mediate metalloprotease-dependent phosphorylation of epidermal growth factor receptor and ErbB3 in human salivary gland cells.
    Ratchford AM; Baker OJ; Camden JM; Rikka S; Petris MJ; Seye CI; Erb L; Weisman GA
    J Biol Chem; 2010 Mar; 285(10):7545-55. PubMed ID: 20064929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation.
    Shi F; Telesco SE; Liu Y; Radhakrishnan R; Lemmon MA
    Proc Natl Acad Sci U S A; 2010 Apr; 107(17):7692-7. PubMed ID: 20351256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional isolation of activated and unilaterally phosphorylated heterodimers of ERBB2 and ERBB3 as scaffolds in ligand-dependent signaling.
    Zhang Q; Park E; Kani K; Landgraf R
    Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13237-42. PubMed ID: 22733765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic analysis of the epidermal growth factor (EGF) receptor-ErbB2-ErbB3 protein network by luciferase fragment complementation imaging.
    Macdonald-Obermann JL; Adak S; Landgraf R; Piwnica-Worms D; Pike LJ
    J Biol Chem; 2013 Oct; 288(42):30773-30784. PubMed ID: 24014028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGF and NRG induce phosphorylation of HER3/ERBB3 by EGFR using distinct oligomeric mechanisms.
    van Lengerich B; Agnew C; Puchner EM; Huang B; Jura N
    Proc Natl Acad Sci U S A; 2017 Apr; 114(14):E2836-E2845. PubMed ID: 28320942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERBB3 (HER3) is a key sensor in the regulation of ERBB-mediated signaling in both low and high ERBB2 (HER2) expressing cancer cells.
    Choi BK; Fan X; Deng H; Zhang N; An Z
    Cancer Med; 2012 Aug; 1(1):28-38. PubMed ID: 23342251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligomers of ERBB3 have two distinct interfaces that differ in their sensitivity to disruption by heregulin.
    Kani K; Warren CM; Kaddis CS; Loo JA; Landgraf R
    J Biol Chem; 2005 Mar; 280(9):8238-47. PubMed ID: 15611073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An EGFR wild type-EGFRvIII-HB-EGF feed-forward loop regulates the activation of EGFRvIII.
    Li L; Chakraborty S; Yang CR; Hatanpaa KJ; Cipher DJ; Puliyappadamba VT; Rehman A; Jiwani AJ; Mickey B; Madden C; Raisanen J; Burma S; Saha D; Wang Z; Pingle SC; Kesari S; Boothman DA; Habib AA
    Oncogene; 2014 Aug; 33(33):4253-64. PubMed ID: 24077285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.
    Feroz K; Williams E; Riese DJ
    Cell Signal; 2002 Sep; 14(9):793-8. PubMed ID: 12034361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic insights into differential requirement of receptor dimerization for oncogenic activation of mutant EGFR and its clinical perspective.
    Cho J
    BMB Rep; 2020 Mar; 53(3):133-141. PubMed ID: 32172728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinase-mediated quasi-dimers of EGFR.
    Bublil EM; Pines G; Patel G; Fruhwirth G; Ng T; Yarden Y
    FASEB J; 2010 Dec; 24(12):4744-55. PubMed ID: 20682838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ analysis of mutant EGFRs prevalent in glioblastoma multiforme reveals aberrant dimerization, activation, and differential response to anti-EGFR targeted therapy.
    Gajadhar AS; Bogdanovic E; Muñoz DM; Guha A
    Mol Cancer Res; 2012 Mar; 10(3):428-40. PubMed ID: 22232519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Her4 and Her2/neu tyrosine kinase domains dimerize and activate in a reconstituted in vitro system.
    Monsey J; Shen W; Schlesinger P; Bose R
    J Biol Chem; 2010 Mar; 285(10):7035-44. PubMed ID: 20022944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinase activator-receiver preference in ErbB heterodimers is determined by intracellular regions and is not coupled to extracellular asymmetry.
    Ward MD; Leahy DJ
    J Biol Chem; 2015 Jan; 290(3):1570-9. PubMed ID: 25468910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells.
    Brockhoff G; Heiss P; Schlegel J; Hofstaedter F; Knuechel R
    Cytometry; 2001 Aug; 44(4):338-48. PubMed ID: 11500850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ErbB3 expression and dimerization with EGFR influence pancreatic cancer cell sensitivity to erlotinib.
    Frolov A; Schuller K; Tzeng CW; Cannon EE; Ku BC; Howard JH; Vickers SM; Heslin MJ; Buchsbaum DJ; Arnoletti JP
    Cancer Biol Ther; 2007 Apr; 6(4):548-54. PubMed ID: 17457047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homo- and Heteroassociations Drive Activation of ErbB3.
    Váradi T; Schneider M; Sevcsik E; Kiesenhofer D; Baumgart F; Batta G; Kovács T; Platzer R; Huppa JB; Szöllősi J; Schütz GJ; Brameshuber M; Nagy P
    Biophys J; 2019 Nov; 117(10):1935-1947. PubMed ID: 31653451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric tyrosine kinase arrangements in activation or autophosphorylation of receptor tyrosine kinases.
    Bae JH; Schlessinger J
    Mol Cells; 2010 May; 29(5):443-8. PubMed ID: 20432069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.